Dosage and usage of dextroamphetamine transdermal patch

Dextroamphetamine Transdermal System (Dextroamphetamine Transdermal System), as a central nervous system stimulant, is commonly used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Compared with oral medications, transdermal patches provide stable drug release and reduce drug volatility, making them a more suitable treatment option for some patients.

The use of dextroamphetamine transdermal patches is relatively simple. Each patch should be used once a day. The skin should be clean, hairless, and undamaged, such as the back, buttocks, or outer thighs. The use time of each patch is 24 hours, and the patches should be replaced regularly to avoid long-term use of the same site. When using, make sure the patch fits tightly against the skin to avoid leakage of medicine or peeling off of the patch. When changing patches, patients should use the new patch and avoid reusing the old patch.

When using dextroamphetamine transdermal patches, patients especially need to avoid the drug coming into contact with the eyes, mouth or other mucosal areas to prevent unnecessary irritation or discomfort. The patch should be stored in a cool, dry place away from direct sunlight and humid environments to ensure the stability of the drug. For patients who cannot tolerate the side effects of the drug or have allergic skin reactions, they should communicate with their doctor immediately, and the medication regimen may need to be adjusted.

The dose of dextroamphetamine transdermal patch is usually individualized based on the patient's age, condition, and response to the drug. When treatment begins, it is common to start with a low dose and gradually increase to achieve optimal results. Doctors will adjust dosage and monitor side effects based on patient response and efficacy. Before starting this medication, patients should discuss their medication plan and potential risks with their doctor in detail.

References: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215401s000lbl.pdf